Al-Razi Medical Company (TADAWUL:9572)

Al-Razi Medical Company Ratios and Metrics

Market cap in millions SAR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jan 20, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	46	90	91	-	-
Market Cap Growth	-48.27%	-1.34%	-	-	-
Enterprise Value	59	98	97	-	-
Last Close Price	30.52	59.00	59.80	-	-
PE Ratio	164.68	509.93	132.51	-	-
PS Ratio	0.72	1.46	1.48	-	-
PB Ratio	2.04	3.96	4.06	-	-
P/TBV Ratio	2.06	4.03	4.15	-	-
P/FCF Ratio	57.11	81.55	91.19	-	-
P/OCF Ratio	11.79	18.09	15.73	-	-
EV/Sales Ratio	0.92	1.60	1.59	-	-
EV/EBITDA Ratio	11.56	36.62	32.66	-	-
EV/EBIT Ratio	41.83	94.35	62.66	-	-
EV/FCF Ratio	72.85	89.31	97.71	-	-
Debt / Equity Ratio	0.58	0.38	0.48	0.32	0.27
Debt / EBITDA Ratio	2.56	1.78	2.04	1.45	1.49
Debt / FCF Ratio	16.11	7.86	10.73	-	-
Asset Turnover	1.34	1.42	1.39	1.26	-
Inventory Turnover	2.21	2.23	1.98	1.84	-
Quick Ratio	0.29	0.27	0.14	0.19	0.89
Current Ratio	1.56	1.92	1.79	2.07	2.61
Return on Equity (ROE)	1.25%	0.78%	2.99%	8.43%	-
Return on Assets (ROA)	1.85%	1.51%	2.20%	3.88%	-
Return on Invested Capital (ROIC)	2.62%	2.02%	3.02%	5.19%	-
Return on Capital Employed (ROCE)	4.20%	3.50%	5.00%	8.60%	8.20%
Earnings Yield	0.61%	0.20%	0.76%	-	-
FCF Yield	1.75%	1.23%	1.10%	-	-
Dividend Yield	5.20%	-	2.65%	-	-
Payout Ratio	-	-	351.72%	93.81%	-
Total Shareholder Return	5.20%	-	2.65%	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.